|
GOLIM4 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63539959352477E-10 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.9023006220541E-11 |
| Normal-vs-Stage2 |
9.10679998078479E-09 |
| Normal-vs-Stage3 |
3.64999999999949E-05 |
| Normal-vs-Stage4 |
4.40560000003476E-06 |
| Stage1-vs-Stage2 |
7.459800E-01 |
| Stage1-vs-Stage3 |
2.110800E-01 |
| Stage1-vs-Stage4 |
7.317200E-01 |
| Stage2-vs-Stage3 |
2.217800E-01 |
| Stage2-vs-Stage4 |
9.094400E-01 |
| Stage3-vs-Stage4 |
3.230400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.7676975962504E-11 |
| Normal-vs-AfricanAmerican |
3.3044999958598E-08 |
| Normal-vs-Asian |
2.440400E-04 |
| Caucasian-vs-AfricanAmerican |
5.677200E-01 |
| Caucasian-vs-Asian |
7.704400E-01 |
| AfricanAmerican-vs-Asian |
5.915200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.64246394263046E-12 |
| Normal-vs-Female |
8.04600000000599E-05 |
| Male-vs-Female |
1.002490E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.58219999826892E-08 |
| Normal-vs-Extreme_Weight |
8.98110474878422E-11 |
| Normal-vs-Obese |
5.73680000170995E-08 |
| Normal-vs-Extreme_Obese |
6.00949999999267E-05 |
| Normal_Weight-vs-Extreme_Weight |
6.647000E-01 |
| Normal_Weight-vs-Obese |
3.930400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.020400E-01 |
| Extreme_Weight-vs-Obese |
1.344350E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.037000E-01 |
| Obese-vs-Extreme_Obese |
7.978600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.25220000041426E-07 |
| Normal-vs-Age(41-60Yrs) |
1.90429999546993E-08 |
| Normal-vs-Age(61-80Yrs) |
2.75857114928613E-12 |
| Normal-vs-Age(81-100Yrs) |
8.64130000000074E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.986000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.593600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.509800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.112200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.975600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.392600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.17380019435143E-10 |
| Normal-VS-Type2 PRCC |
9.27459997690505E-10 |
| Normal-VS-KIRP CIMP |
2.407000E-04 |
| Normal-VS-Unclassified PRCC |
6.430700E-04 |
| Type1 PRCC-VS-Type2 PRCC |
8.627000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.407000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.408770E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.705000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.004600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.653000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.67650004989639E-09 |
| Normal-vs-N1 |
2.18590000000685E-06 |
| Normal-vs-N2 |
6.175000E-03 |
| N0-vs-N1 |
3.030200E-01 |
| N0-vs-N2 |
8.133000E-01 |
| N1-vs-N2 |
8.072200E-01 |
|
|
